Democratizing hedge fund level analysis tools for everyone
Name | Indofarma Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Bio Farma (Persero) | 80.66 | 80.66 |
Public < 5% | 11.99 | 11.99 |
PT. Asabri (Persero) - Dapen Tni | 7.34 | 7.34 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Engineering Pharmaceutical | 0.0% | 0.0% |
Medicine | 65.3% | 48.6% |
Medical Devices & Others | 34.7% | 51.4% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 2.91 | # 14 / 15 |
EV_EBITDA | -24.13 | --- / 15 |
PER | -4.48 | --- / 15 |
PBV | -0.47 | --- / 15 |
DER | -1.69 | --- / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | -65.0 | --- / 15 |
ROA % | -15.6 | --- / 15 |
ROE % | 10.5 | --- / 15 |
Year | DPS | Yield [%] |
---|
Timeframe | Performance |
---|---|
1W % | -3.1 |
1Mo % | -45.2 |
3Mo % | -68.8 |
1Yr % | -79.7 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
INAF | -4.48 | 391 B | 1.75 T | 134 B | -73 B | -87 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |